STE STERIS plc

Price (delayed)

$199.45

Market cap

$17.03B

P/E Ratio

42.8

Dividend/share

$1.6

EPS

$4.66

Enterprise value

$18.61B

Steris Corporation is an American Irish-domiciled medical equipment company specializing in sterilization and surgical products for the US healthcare system. Steris is operationally headquartered in Mentor, Ohio, but has been ...

Highlights
The company's equity rose by 14% YoY
The revenue has grown by 2.5% YoY
STERIS's debt has increased by 40% YoY but it has decreased by 3.3% from the previous quarter
STERIS's quick ratio has decreased by 20% YoY and by 10% from the previous quarter
STE's P/E is 17% above its last 4 quarters average of 36.3 and 14% above its 5-year quarterly average of 37.4

Key stats

What are the main financial stats of STE
Market
Shares outstanding
85.37M
Market cap
$17.03B
Enterprise value
$18.61B
Valuations
Price to earnings (P/E)
42.8
Price to book (P/B)
4.39
Price to sales (P/S)
5.48
EV/EBIT
33.52
EV/EBITDA
24.03
EV/Sales
5.99
Earnings
Revenue
$3.11B
EBIT
$555.24M
EBITDA
$774.48M
Free cash flow
$450.95M
Per share
EPS
$4.66
Free cash flow per share
$5.28
Book value per share
$45.47
Revenue per share
$36.41
TBVPS
$31.05
Balance sheet
Total assets
$6.57B
Total liabilities
$2.68B
Debt
$1.8B
Equity
$3.88B
Working capital
$633.83M
Liquidity
Debt to equity
0.46
Current ratio
2.1
Quick ratio
1.44
Net debt/EBITDA
2.04
Margins
EBITDA margin
24.9%
Gross margin
43.2%
Net margin
12.8%
Operating margin
17.6%
Efficiency
Return on assets
6.6%
Return on equity
10.7%
Return on invested capital
16.8%
Return on capital employed
9.3%
Return on sales
17.9%
Dividend
Dividend yield
0.8%
DPS
$1.6
Payout ratio
34.3%

STE stock price

How has the STERIS stock price performed over time
Intraday
0.62%
1 week
2%
1 month
0.84%
1 year
28.76%
YTD
5.23%
QTD
4.71%

Financial performance

How have STERIS's revenue and profit performed over time
Revenue
$3.11B
Gross profit
$1.34B
Operating income
$548.37M
Net income
$397.4M
Gross margin
43.2%
Net margin
12.8%
STERIS's net margin has decreased by 9% from the previous quarter and by 5% YoY
The company's net income fell by 8% QoQ and by 2.5% YoY
STE's operating margin is down by 3.8% since the previous quarter
The revenue has grown by 2.5% YoY

Growth

What is STERIS's growth rate over time

Valuation

What is STERIS stock price valuation
P/E
42.8
P/B
4.39
P/S
5.48
EV/EBIT
33.52
EV/EBITDA
24.03
EV/Sales
5.99
STE's P/E is 17% above its last 4 quarters average of 36.3 and 14% above its 5-year quarterly average of 37.4
The company's EPS fell by 8% QoQ and by 3.1% YoY
STE's P/B is 41% above its 5-year quarterly average of 3.1 and 6% above its last 4 quarters average of 4.1
The company's equity rose by 14% YoY
The P/S is 51% above the 5-year quarterly average of 3.6 and 9% above the last 4 quarters average of 5.0
The revenue has grown by 2.5% YoY

Efficiency

How efficient is STERIS business performance
STERIS's ROA has decreased by 14% YoY and by 13% from the previous quarter
The ROE has decreased by 13% YoY and by 11% from the previous quarter
STERIS's ROIC has decreased by 8% YoY and by 7% from the previous quarter
The company's return on sales fell by 3.2% QoQ

Dividends

What is STE's dividend history
DPS
$1.6
Dividend yield
0.8%
Payout ratio
34.3%
Recent dividends

Financial health

How did STERIS financials performed over time
The total assets is 145% more than the total liabilities
STE's total liabilities is up by 33% year-on-year
The total assets has grown by 21% YoY
STERIS's debt is 54% less than its equity
STERIS's debt has increased by 40% YoY but it has decreased by 3.3% from the previous quarter
STE's debt to equity is up by 21% year-on-year but it is down by 4.2% since the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.